Picture of Redhill Biopharma logo

RDHL — Redhill Biopharma News Story

0.000.00%
us flag iconLast trade - 00:00
HealthcareSpeculativeMicro CapSucker Stock

Brief: Redhill Announces New Opaganib Chinese Patent Against Ebola Virus Valid Through 2035

May 6 (Reuters) - Redhill Biopharma Ltd  2RH0y.F :
    * REDHILL ANNOUNCES NEW OPAGANIB CHINESE PATENT AGAINST
EBOLA
VIRUS VALID THROUGH 2035

Source text for Eikon:  ID:nPnbT2xJta 
Further company coverage:  2RH0y.F 

 ((Reuters.Briefs@thomsonreuters.com;))

Recent news on Redhill Biopharma

See all news